The Importance of ENDING-S Score in the Diagnosis of Palliative Patients in the Intensive Care Unit
1 other identifier
observational
135
1 country
1
Brief Summary
In our study, we aim to predict palliative care patients earlier, to reduce hospitalization periods and to prevent intensive care unit occupation by palliative care patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedFirst Submitted
Initial submission to the registry
January 30, 2021
CompletedFirst Posted
Study publicly available on registry
April 29, 2021
CompletedApril 29, 2021
April 1, 2021
1.1 years
January 30, 2021
April 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Recognition of palliative care unit patients before intensive care discharge
ENDING-S Scoring system used to predict patients who were followed up in intensive care units and discharged to palliative care unit during their hospitalization. We aim to identify patients who are likely to be admitted to palliative care centers following their admission to intensive care units, and to prepare a palliative care center before the discharge from the intensive care.
Fourth day of intensive care follow up
Eligibility Criteria
Intensive care patients
You may qualify if:
- Patients older than 18 years will be included in the study. Patients staying longer than 48 hours intensive care will be included in the study.
You may not qualify if:
- Patients younger than 18 years. Patients staying less than 48 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ministry of Health Ankara City Hospital
Ankara, 06800, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Işıl Özkoçak Turan, Prof.
Ministry of Health Ankara City Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist MD
Study Record Dates
First Submitted
January 30, 2021
First Posted
April 29, 2021
Study Start
June 1, 2019
Primary Completion
July 8, 2020
Study Completion
December 30, 2020
Last Updated
April 29, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share